
Health Check: Promedicus shares smash record $300 barrier on back of mega deals
Promedicus shares have smashed a record – but not this one – by soaring over the $300 level. Pic via Getty Defying the sceptics, Promedicus announces $190 million of new US contracts Proteomics wins US reimbursement code for its diabetic kidney disease …